Redeye Feed

2026-11-04 17:56:00 Cantargia: Early Haematology Signal Ahead of ASH Oral

2026-11-04 17:55:00 Intervacc (Q3 Preview): Focus on upcoming catalysts

2026-11-04 17:54:00 Freja eID: Teracom framework agreement opens up to SEK27.9m in ARR, far beyond our assumptions

2026-11-04 17:53:00 Magle Group: Preliminary Q3 figures ahead of delisting

2026-11-04 11:04:00 RaySearch Laboratories (Q4 Review): Strong Q4 needed to restore confidence

2026-11-04 11:02:00 Truecaller (Q3 Review): Selloff overdone – revenue growth beats user slowdown

2026-11-04 11:01:00 Hacksaw (Q3 Review): Uncertain timing of growth recovery

2026-11-04 11:00:00 NYORDA (Q3 Review): Broad-Based Growth at Single-Digit Multiples

2026-11-03 16:43:00 INQ Group: Foreign capital at improved terms, and more deals guided for Q4

2026-11-03 16:42:00 Fable Media Group: Comment on guidance adjustment

2026-11-03 16:41:00 I-Tech: EU vote as expected

2026-11-03 16:40:00 Genovis (Q3 preview): Expecting a solid release

2026-11-03 16:39:00 CombinedX: Enqore sold at 10x EBITA and further AI investment

2026-11-03 16:38:00 Freemelt: Rights issue of ~SEK 152m

2026-11-03 13:31:00 Weekly Edge Case – Bonesupport

2026-11-03 11:08:00 Moberg Pharma: Moberg Pharma: U.S. patent extends IP runway to end of 2041

2026-11-03 11:07:00 Lytix Biopharma: NeoLIPA hits primary endpoint

2026-11-03 11:06:00 Invisio (Q3 Review): Strong order intake supports a solid year-end

2026-11-03 11:05:00 Freemelt (Q3 Preview): Building the order backlog

2026-11-03 11:04:00 Smart Eye (Q3 Preview): Summer seasonality mid EU ramp

2026-11-02 14:16:00 Alligator Bioscience: Mitazalimab sold to Biossil

2026-11-02 14:14:00 Paxman: First CIPN order

2026-11-02 14:13:00 CTEK (Q3 Review): Back to growth, margins keep surprising

2026-11-02 14:12:00 Indutrade (Q3 review): Orders keep building

2026-10-30 14:16:00 Enviro (Q3 Review): Reconstruction enters its final phase

2026-10-30 14:15:00 Transtema (Q3 Preliminary): Sweden solid, Norway sees significant decline and is written down

2026-10-30 14:14:00 CLS: Industry partner in NCI-funded programme for spinal metastases

2026-10-30 14:13:00 BioInvent (Q3 Review): Rights Issue to Fund Part C

2026-10-30 14:12:00 Senzime (Q3 Review): Recovery under way

2026-10-30 14:11:00 Lifco (Q3 Review): Margins hold, but a customer leaves

2026-10-29 18:12:00 Sdiptech (Q3 review): Sales beat, Base Case raised to SEK315

2026-10-29 14:20:00 Weekly Edge Case – Lime Technologies

2026-10-29 12:22:00 Initiator Pharma: Last patient dosed, topline data now expected in February 2027

2026-10-29 12:21:00 BioArctic: Leqembi Q3 royalties in line with estimates

2026-10-29 12:20:00 GiG Software (Q3 Review): Guidance supports raised estimates

2026-10-29 12:20:00 Catella (Q3 Preview): Stronger euro, weaker deal market

2026-10-29 12:19:00 TagMaster (Q3 Review): Solid performance in a slow market

2026-10-29 12:19:00 BioInvent: SEK430m Rights Issue, but Owner Support Is Thin

2026-10-29 12:18:00 Avensia (Q3 Review): Margin recovery arrives ahead of the savings – 10% EBIT margin within reach 2027

2026-10-29 12:18:00 SSH (Q3 Review): Privileged Growth

2026-10-28 11:53:00 Magle Group: Delisting application submitted

2026-10-28 11:52:00 AlzeCure: Change of CEO as the company enters a new phase

2026-10-28 11:50:00 Xbrane Biopharma: Lucamzi approved by the FDA

2026-10-28 11:47:00 NextCell Pharma: Initial comments on the data

2026-10-28 11:46:00 Oncopeptides (Q3 Preview): Operating Leverage in Focus

2026-10-28 11:45:00 Neem’s Hill (Q3 Review): Underlying progress points to sales growth

2026-10-27 17:37:00 Camurus (Q3 preview): Expecting Continued Growth

2026-10-27 17:36:00 Safeture (Q3 Review): Trimming Estimates, Valuation Remains Attractive

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode